Islet amyloid polypeptide/amylin messenger RNA and protein expression in human insulinomas in relation to amyloid formation

European Journal of Endocrinology

Volumn 140, Issue 1, 1999, Pages 69-78

  Van Hulst, K L ^a   Oosterwijk, C ^a   Born, W ^b   Vroom, Th M ^a   Nieuwenhuis, M G ^a   Blankenstein, M A ^a   Lips, C J M ^a   Fischer, J A ^b   Hoppener J W M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; AMYLOID; INSULIN; MESSENGER RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INSULINOMA; MALE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; AMYLOID; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMOGRANIN A; CHROMOGRANINS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN; INSULINOMA; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PANCREATIC NEOPLASMS; PROTEIN PRECURSORS; RNA, MESSENGER;

EID: 0033011022     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1400069     Document Type: Article

References (39)

1. Service FJ, McMahon MM, O'Brien PC & Ballard DJ. Functioning insulinoma. Incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clinic Proceedings 1991 66 711-719.
2. Westermark P, Grimelius L, Polak JM, Larsson LI, van Noorden S, Wilander E & Pearse AGE. Amyloid polypeptide hormone-producing tumours. Laboratory Investigation 1977 37 212-215.
3. Clark A, Foulis AK, McLay A, Ostle LR, Brownie A & Morris JF, Formation of amyloid in insulinomas: analysis by immunohistocheinistry. Journal of Endorinology 1989 123 (Suppl) Abstract 164.
4. O'Brien TD, Butler AE, Roche PC, Johnson KH & Butler PC. Islet amyloid polypeptide in human insulinoma. Evidence for intracellular amyloidogenesis. Diabetes 1994 43 329-336.
5. Westermark P, Wernstedt C, Wilander E & Sletten K. A novel peptide in the calcitonin gene-related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochemical and Biophysical Research Communications 1986 140 827-831.
6. Westermark P, Wernstedt C, Wilander E, Hayden DW, O'Brien TD & Johnson KH. Amyloid fibrils in human insulinoma and islets of Langerhans in the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proceedings of the National Academy of Sciences of the USA 1987 84 3881-3885.
7. Cooper GJS, Willis AC, Clark A, Turner RC, Sim RB & Reid KBM, Purification and characterization of a peptide from amyloidrich pancreases of type 2 diabetic patients. Proceedings of the National Academy of Sciences of the USA 1987 84 8628-8632.
8. Cooper GJS, Leighton B, Dimitriadis GD, Parry-Billings M, Kowalchuk JM, Howland K et al. Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle. Proceedings of the National Academy of Sciences of the USA 1988 85 7765-7766.
9. Höppener JWM, Oosterwijk C, van Hulst KL, Verbeek JS, Capel PJA, de Koning EJP et al. Molecular physiology of the islet amyloid polypeptide (IAPP)/amylin gene in man, rat and transgenic mice. Journal of Cellular Biochemistry 1994 55S 39-53.
10. Kahn SE, D'Alessio DA, Schwartz MW, Fujimoto WY, Ensinck JW, Taborsky GJ & Porte D. Evidence of cosecretion of islet amyloid polypeptide and insulin by β cells. Diabetes 1990 39 634-638.
11. van Hulst KL, Hackeng WHL, Höppener JWM, van Jaarsveld BC, Nieuwenhuis MG, Blankenstein MA & Lips CJM. An improved method for the determination of islet amyloid polypeptide levels in plasma. Annals of Clinical Biochemistry 1994 51 165-170.
12. Sanke T, Bell GI, Sample C, Rubenstein AH & Steiner DF. An islet amyloid polypeptide is derived from an 89-amino acid precursor by proteolytic processing. Journal of Biological Chemistry 1988 263 17243-17246.
13. Mosselman S, Höppener JWM, Lips CJM & Jansz HS. The complete islet amyloid polypeptide precursor is encoded by two exons. FEBS Letters 1989 247 154-158.
14. Cooper GJS. Amylin compared with calcitonin gene-related peptide: structure, biology, and relevance to metabolic disease. Endocrine Reviews 1994 15 165-201.
15. Putchler H, Sweat F & Levine M. On the binding of Congo red by amyloid. Journal of Histochemistry and Cytochemistry 1962 10 355-364.
16. van der Leede B-JM, Geertzema J, Vroom ThM, Décimo D, Lutz Y, van der Saag PT & van der Burg B. Immunohistochemical analysis of retinoic acid receptor-α in human breast tumours. RAR-α expression correlates with proliferate activity. American Journal of Pathology 1996 148 1905-1914.
17. Chirgwin JM, Przybyla AE, MacDonald RJ & Rutten WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979 18 5294-5299.
18. van Hulst KL, Born W, Muff R, Oosterwijk C, Blankenstein MA, Lips CJM et al. Biologically active human islet amyloid polypeptide/amylin in transgenic mice. European Journal of Endocrinology 1997 136 107-113.
19. Burton KA. A study of the conditions and mechanism of the diphenylainine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochemistry 1956 62 315-523.
20. Höppener JWM, Verbeek JS, de Koning EJP, Oosterwijk C, van Hulst KL, Visser-Vernooy HJ et al. Chronic overproduction of islet amyloid polypeptide (IAPP)/amylin in transgenic mice: lysosomal localization of human IAPP and lack of marked hyperglycaemia or hyperinsulinaemia. Diabetologia 1993 36 1258-1265.
21. Church GM & Gilbert W. Genomic sequencing. Proceedings of the National Academy of Sciences of the USA 1984 81 1991-1995.
22. van Hulst KL, Höppener JWM, Berends MJH, Nieuwenhuis MG, Blankenstein MA & Lips CJM. Characterization of antibodies against human islet amyloid polypeptide (IAPP)/amylin and its C-terminal flanking peptide (C-proIAPP). European Journal of Endocrinology 1994 130 (Suppl 2) 196.
23. Gedulin B, Cooper GJS & Young AA. Amylin secretion from the perfused pancreas: dissociation from insulin and abnormal elevation in insulin-resistant diabetic rats. Biochemical and Biophysical Research Communications 1991 80 782-789.
24. O'Brien TD, Westermark P & Johnson KH. Islet amyloid polypeptide and insulin secretion from isolated perfused pancreas of fed, fasted, glucose-treated, and dexamethasone-treated rats. Diabetes 1991 40 1701-1706.
25. Novials A, Sarri Y, Casamitjana R, Rivera F & Gomis R. Regulation of islet amyloid polypeptide in human pancreatic islets. Diabetes 1993 42 1514-1519.
26. Creutzfeldt W, Creutzfeldt C, Frerichs H, Track NS & Arnold R. Histochemistry, ultrastructure, and hormone content of human insulinomas. Hormone and Metabolic Research 1976 (Suppl 6) 7-18.
27. Pipeleers DG. Heterogeneity in pancreatic β cell population. Diabetes 1992 41 777-781.
28. Bretherton-Watt D, Ghatei MA, Bloom SE, Williams S & Bloom SR. Islet amyloid polypeptide-like immunoreactivity in human tissue and endocrine tumours. Journal of Clinical Endocrinology and Metabolism 1993 76 1072-1074.
29. Stridsberg M, Eriksson B, Lundqvist G, Skogseid B, Wilander E & Öberg K. Islet amyloid polypeptide (IAPP) in patients with neuroendocrine tumours. Regulatory Peptides 1995 55 119-131.
30. Tasaka Y, Nakaya F, Matsumoto H, Iwamoto Y & Omori Y. Pancreatic amylin content in human diabetic subjects and its relation to diabetes. Pancreas 1995 11 505-308.
31. de Koning EJP, Höppener JWM, Verbeek JS, Oosterwijk C, van Hulst KL, Baker CA et al. Human islet amyloid polypeptide accumulates at similar sites in islets of transgenic mice and humans. Diabetes 1994 43 640-644.
32. de Koning EJP, Morris ER, Hofhuis FMA, Posthuma G, Höppener JWM, Morris JF et al. Intra-and extracellular amyloid fibrils are formed in cultured pancreatic islets of transgenic mice expressing human islet amyloid polypeptide. Proceedings of the National Academy of Sciences of the USA 1994 91 8467-8471.
33. Verchere CB, D'Alessio DA, Palmiter RD, Weir GC, Bonner-Weir S, Baskin DG & Kahn SE. Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide. Proceedings of the National Academy of Sciences of the USA 1996 93 3492-3496.
34. Janson J, Soeller WC, Roche PC, Nelson RT, Torchia AJ, Kreutter DK & Butler PC. Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide. Proceedings of the National Academy of Sciences of the USA 1996 93 7283-7288.
35. vy/a mice expressing human islet amyloid polypeptide. Diabetes 1998 47 743-750.
36. de Koning EJP, Bodkin NL, Hansen BC & Clark A. Diabetes mellitus in Macaca mulatta monkeys is characterised by islet amyloidosis and reduction in beta-cell population. Diabetologia 1993 36 378-384.
37. Oosterwijk C, Höppener JWM, van Hulst KL & Lips CJM. Pancreatic islet amyloid formation in patients with non-insulin-dependent diabetes mellitus. Implication for therapeutic strategy. International Journal of Pancreatology 1995 18 7-14.
38. Höppener JWM, Oosterwijk C, Visser-Vernooy HJ, Lips CJM & Jansz HS. Characterization of the human islet amyloid polypeptide/amylin gene transcripts: identification of a new polyadenylation site. Biochemical and Biophysical Research Communications 1992 189 1569-1577.
39. Nieuwenhuis MG, van Mansfeld ADM, van Unnik JAM, Berends MJH & Lips CJM. No constant relationship between islet amyloid polypeptide (IAPP) and insulin expression in insulinomas. Netherlands Journal of Medicine 1992 41 264-271.